| Product Code: ETC10939480 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Vaccine Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Malaysia Vaccine Market - Industry Life Cycle |
3.4 Malaysia Vaccine Market - Porter's Five Forces |
3.5 Malaysia Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Malaysia Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Malaysia Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Malaysia Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Malaysia Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Malaysia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government focus on public health initiatives, including vaccination programs. |
4.2.2 Growing awareness about the importance of vaccination in preventing diseases. |
4.2.3 Rising incidence of infectious diseases driving the demand for vaccines. |
4.3 Market Restraints |
4.3.1 Challenges related to vaccine distribution and logistics, especially in remote areas. |
4.3.2 Vaccine hesitancy among certain segments of the population impacting vaccination rates. |
5 Malaysia Vaccine Market Trends |
6 Malaysia Vaccine Market, By Types |
6.1 Malaysia Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Vaccine Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Malaysia Vaccine Market Revenues & Volume, By Preventive Vaccines, 2021 - 2031F |
6.1.4 Malaysia Vaccine Market Revenues & Volume, By Therapeutic Vaccines, 2021 - 2031F |
6.1.5 Malaysia Vaccine Market Revenues & Volume, By DNA Vaccines, 2021 - 2031F |
6.2 Malaysia Vaccine Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Vaccine Market Revenues & Volume, By Influenza, 2021 - 2031F |
6.2.3 Malaysia Vaccine Market Revenues & Volume, By COVID19, 2021 - 2031F |
6.2.4 Malaysia Vaccine Market Revenues & Volume, By Hepatitis B, 2021 - 2031F |
6.3 Malaysia Vaccine Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Malaysia Vaccine Market Revenues & Volume, By Pediatrics, 2021 - 2031F |
6.3.3 Malaysia Vaccine Market Revenues & Volume, By Adults, 2021 - 2031F |
6.3.4 Malaysia Vaccine Market Revenues & Volume, By Geriatrics, 2021 - 2031F |
6.4 Malaysia Vaccine Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Malaysia Vaccine Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.4.3 Malaysia Vaccine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4.4 Malaysia Vaccine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.5 Malaysia Vaccine Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Malaysia Vaccine Market Revenues & Volume, By mRNAbased, 2021 - 2031F |
6.5.3 Malaysia Vaccine Market Revenues & Volume, By Viral Vector, 2021 - 2031F |
6.5.4 Malaysia Vaccine Market Revenues & Volume, By Protein Subunit, 2021 - 2031F |
7 Malaysia Vaccine Market Import-Export Trade Statistics |
7.1 Malaysia Vaccine Market Export to Major Countries |
7.2 Malaysia Vaccine Market Imports from Major Countries |
8 Malaysia Vaccine Market Key Performance Indicators |
8.1 Immunization coverage rate among target population groups. |
8.2 Number of new vaccines introduced in the market. |
8.3 Investment in research and development for new vaccines. |
8.4 Number of partnerships and collaborations between government and pharmaceutical companies for vaccine development. |
8.5 Vaccine uptake rate among different age groups. |
9 Malaysia Vaccine Market - Opportunity Assessment |
9.1 Malaysia Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Malaysia Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Malaysia Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.4 Malaysia Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Malaysia Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Malaysia Vaccine Market - Competitive Landscape |
10.1 Malaysia Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Malaysia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here